background image

Paid Clinical Trials Iowa City

Discover 516 paid clinical trials in Iowa City, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Psilocybin-Assisted Vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder

Recruiting
PHASE2

Sponsor:

Peggy C Nopoulos

Location:

Iowa CIty IA

Code:

NCT05421065

Conditions

Alcohol Use Disorder

Eligibility Criteria

Sex: Male

Age: 25 - 65

Healthy Volunteers: Not accepted

Interventions

Psilocybin

Ketamine

Empagliflozin Treatment in Kidney Transplant Recipients

Recruiting

Sponsor:

VA Office of Research and Development

Location:

Iowa City IA, Omaha NE, Nashville TN, Pittsburgh PA

Code:

NCT06013865

Conditions

Kidney Transplant

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Interventions

Empagliflozin

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting
PHASE3

Sponsor:

Children's Oncology Group

Location:

Iowa City IA, Des Moines IA, Peoria IL, Madison WIshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Recruiting
PHASE2

Sponsor:

MeiraGTx, LLC

Location:

Iowa City IA, Columbia MO, Detroit MI, Pittsburgh PAshow 13 more

Code:

NCT05926765

Conditions

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AAV2-hAQP1 Concentration 1

AAV2-hAQP1 Concentration 2

Placebo

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting
PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Iowa City IA, Saint Peters MO, Milwaukee WI, Minneapolis MNshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Spastic Paraplegia - Centers of Excellence Research Network

Recruiting

Sponsor:

Boston Children's Hospital

Location:

Iowa City IA, Ann Arbor MI, Cincinnati OH, Dallas TXshow 5 more

Code:

NCT06553976

Conditions

Hereditary Spastic Paraplegia

Primary Lateral Sclerosis

SPG4

SPG5A

Spastic Paraplegia 4

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Recruiting
PHASE1
PHASE2

Sponsor:

Mohammed Milhem

Location:

Iowa City IA

Code:

NCT05363631

Conditions

Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma Metastatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selenomethionine (SLM)

Axitinib

Pembrolizumab

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

Recruiting
PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Iowa City IA, Springfield IL, Hinsdale IL, Kansas City MOshow 29 more

Code:

NCT05963074

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Venetoclax

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 Mg) Intravitreal Implants Vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Recruiting
PHASE3

Sponsor:

Jaeb Center for Health Research

Location:

Iowa City IA, Madison WI, Rochester MN, Chicago ILshow 14 more

Code:

NCT05844982

Conditions

Radiation Retinopathy

Visual Impairment

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Faricimab

fluocinolone acetonide

Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Recruiting
PHASE2

Sponsor:

Dwight Owen

Location:

Iowa City IA, Madison WI, Chicago IL, Indianapolis INshow 1 more

Code:

NCT04919382

Conditions

Extensive Stage Lung Small Cell Carcinoma

Metastatic Lung Small Cell Carcinoma

Recurrent Lung Small Cell Carcinoma

Stage IV Lung Cancer AJCC v8

Stage IVA Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Temozolomide